These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

667 related items for PubMed ID: 10910959

  • 1. Identification of the human liver microsomal cytochrome P450s involved in the metabolism of N-nitrosodi-n-propylamine.
    Teiber JF, Hollenberg PF.
    Carcinogenesis; 2000 Aug; 21(8):1559-66. PubMed ID: 10910959
    [Abstract] [Full Text] [Related]

  • 2. Cytochrome P450 2E1 is the principal catalyst of human oxidative halothane metabolism in vitro.
    Spracklin DK, Hankins DC, Fisher JM, Thummel KE, Kharasch ED.
    J Pharmacol Exp Ther; 1997 Apr; 281(1):400-11. PubMed ID: 9103523
    [Abstract] [Full Text] [Related]

  • 3. Identification of human cytochrome P450 isoforms involved in the 3-hydroxylation of quinine by human live microsomes and nine recombinant human cytochromes P450.
    Zhao XJ, Yokoyama H, Chiba K, Wanwimolruk S, Ishizaki T.
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1327-34. PubMed ID: 8968357
    [Abstract] [Full Text] [Related]

  • 4. Kinetic analysis of the activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by heterologously expressed human P450 enzymes and the effect of P450-specific chemical inhibitors on this activation in human liver microsomes.
    Patten CJ, Smith TJ, Murphy SE, Wang MH, Lee J, Tynes RE, Koch P, Yang CS.
    Arch Biochem Biophys; 1996 Sep 01; 333(1):127-38. PubMed ID: 8806763
    [Abstract] [Full Text] [Related]

  • 5. Eight inhibitory monoclonal antibodies define the role of individual P-450s in human liver microsomal diazepam, 7-ethoxycoumarin, and imipramine metabolism.
    Yang TJ, Krausz KW, Sai Y, Gonzalez FJ, Gelboin HV.
    Drug Metab Dispos; 1999 Jan 01; 27(1):102-9. PubMed ID: 9884317
    [Abstract] [Full Text] [Related]

  • 6. Specificity of cDNA-expressed human and rodent cytochrome P450s in the oxidative metabolism of the potent carcinogen 7,12-dimethylbenz[a]anthracene.
    Shou M, Korzekwa KR, Krausz KW, Buters JT, Grogan J, Goldfarb I, Hardwick JP, Gonzalez FJ, Gelboin HV.
    Mol Carcinog; 1996 Dec 01; 17(4):241-9. PubMed ID: 8989918
    [Abstract] [Full Text] [Related]

  • 7. Identification of the cytochrome P450 isozymes involved in the metabolism of N-nitrosodipropyl-,N-nitrosodibutyl- and N-nitroso-n-butyl-n-propylamine.
    Shu L, Hollenberg PF.
    Carcinogenesis; 1996 Apr 01; 17(4):839-48. PubMed ID: 8625499
    [Abstract] [Full Text] [Related]

  • 8. Catalyzation of cocaine N-demethylation by cytochromes P4502B, P4503A, and P4502D in fish liver.
    Arinç E, Bozcaarmutlu A.
    J Biochem Mol Toxicol; 2003 Apr 01; 17(3):169-76. PubMed ID: 12815613
    [Abstract] [Full Text] [Related]

  • 9. Human cytochrome P-450 metabolism of retinals to retinoic acids.
    Zhang QY, Dunbar D, Kaminsky L.
    Drug Metab Dispos; 2000 Mar 01; 28(3):292-7. PubMed ID: 10681373
    [Abstract] [Full Text] [Related]

  • 10. Cytochrome P450-mediated metabolism of haloperidol and reduced haloperidol to pyridinium metabolites.
    Avent KM, DeVoss JJ, Gillam EM.
    Chem Res Toxicol; 2006 Jul 01; 19(7):914-20. PubMed ID: 16841959
    [Abstract] [Full Text] [Related]

  • 11. Metabolic activation of the potent carcinogen dibenzo[a,h]anthracene by cDNA-expressed human cytochromes P450.
    Shou M, Krausz KW, Gonzalez FJ, Gelboin HV.
    Arch Biochem Biophys; 1996 Apr 01; 328(1):201-7. PubMed ID: 8638931
    [Abstract] [Full Text] [Related]

  • 12. Identification of the main human cytochrome P450 enzymes involved in safrole 1'-hydroxylation.
    Ueng YF, Hsieh CH, Don MJ, Chi CW, Ho LK.
    Chem Res Toxicol; 2004 Aug 01; 17(8):1151-6. PubMed ID: 15310247
    [Abstract] [Full Text] [Related]

  • 13. Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes.
    Yamazaki H, Guo Z, Persmark M, Mimura M, Inoue K, Guengerich FP, Shimada T.
    Mol Pharmacol; 1994 Sep 01; 46(3):568-77. PubMed ID: 7935340
    [Abstract] [Full Text] [Related]

  • 14. Metabolic oxidation and toxification of N-methylformamide catalyzed by the cytochrome P450 isoenzyme CYP2E1.
    Hyland R, Gescher A, Thummel K, Schiller C, Jheeta P, Mynett K, Smith AW, Mráz J.
    Mol Pharmacol; 1992 Feb 01; 41(2):259-66. PubMed ID: 1538706
    [Abstract] [Full Text] [Related]

  • 15. Microsomal oxidation of N,N-diethylformamide and its effect on P450-dependent monooxygenases in rat liver.
    Amato G, Longo V, Mazzaccaro A, Gervasi PG.
    Chem Res Toxicol; 1996 Feb 01; 9(5):882-90. PubMed ID: 8828925
    [Abstract] [Full Text] [Related]

  • 16. Roles of human hepatic cytochrome P450s 2C9 and 3A4 in the metabolic activation of diclofenac.
    Tang W, Stearns RA, Wang RW, Chiu SH, Baillie TA.
    Chem Res Toxicol; 1999 Feb 01; 12(2):192-9. PubMed ID: 10027798
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Metabolism of N-nitroso-2,6-dimethylmorpholine by isozymes of rabbit liver microsomal cytochrome P-450.
    Kokkinakis DM, Koop DR, Scarpelli DG, Coon MJ, Hollenberg PF.
    Cancer Res; 1985 Feb 01; 45(2):619-24. PubMed ID: 3967237
    [Abstract] [Full Text] [Related]

  • 19. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes.
    Foroozesh M, Primrose G, Guo Z, Bell LC, Alworth WL, Guengerich FP.
    Chem Res Toxicol; 1997 Jan 01; 10(1):91-102. PubMed ID: 9074808
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.